QST LAB
Desconocido
PAINLESS: Pain relief in palliative care of cancer using home based neuromodulation and predictive biomarkers
QST LAB
participó en un
HORIZON EUROPE:
HORIZON-HLTH-2021-DISEASE-04
More than 50% of cancer patients develop pain before death: 80% can be treated with drugs, but 20% show a low response or have serious adver...
2022-05-20 - 2027-05-31 | Financiado
2022-05-20 - 2027-05-31 | Financiado
* No se disponen de datos de la empresa actual.